Navigation Links
GeneChoice Taq DNA Polymerase With Magnesium Free Standard Buffer from GeneChoice, Inc.

ProductsGeneChoice Taq DNA Polymerase With Magnesium Free Standard Buffer from GeneChoice, Inc.
Company GeneChoice, Inc.
Item GeneChoice Taq DNA Polymerase With Magnesium Free Standard Buffer
Price $215.00
Description • Enzyme concentration - 5 units/µL
• High specific activity and processivity results in higher yields
• Leaves an 'A' overhang
• Processes <3 kb

A thermostable DNA polymerase which exhibits very high activity in primer extension and other molecular biology applications. To ensure the quality of the enzyme, each lot has been functionally tested for maximal activity, specificity, and the absence of any nuclease, nicking, or self-priming activities. Supplied with Magnesium Free Buffer allowing total control of MgCl2 levels. Each Kit contains Taq DNA Polymerase, 10X Mg Free Reaction Buffer, and 25 mM MgCl2.

Enzyme Concentration - 5 units/µL.
10X Magnesium Free Reaction Buffer Components - 100 mM Tris-HCl pH 8.5, 500 mM KCl, 1% Triton X-100.
Info GeneChoice, Inc.GeneChoice, Inc.
7307 Governors Way
Frederick, MD 21703 USA

Call GeneChoice, Inc. to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-772-8354
Customer Service: 866-636-2200
Fax Number: 301-620-0162
Web Site: http://www.genechoiceinc.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. GeneChoice Taq DNA Polymerase With Standard Buffer from GeneChoice, Inc.
2. GeneChoice Taq DNA Polymerase With Ammonium Buffer from GeneChoice, Inc.
3. GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
4. GeneChoice TEMPase II DNA Polymerase from GeneChoice, Inc.
5. T4 DNA Polymerase from Roche Applied Science
6. T4 DNA Polymerase from Roche Applied Science
7. Poly A Polymerase from Invitrogen
8. iTaq DNA Polymerase, 250 U from Bio-Rad
9. iTaq DNA Polymerase, 5,000 U from Bio-Rad
10. Taq DNA Polymerase, 500 U (2 x 250 U) without dNTP from Bioneer, Inc.
11. T4 DNA Polymerase from Invitrogen
...
... siSolutions siRNA Custom Synthesis Service ... duplex RNA to knockdown any ... (19 RNA base pairs with ... 27-mers, or other lengths of ...
...
...
Biology Products:
(Date:2/21/2017)... 2017 Der weltweite Biobanking-Sektor wird ... einem Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen ... gilt, um diese Prognose zu realisieren. ... Zu den ... finanziellen Mittel für die Biobank, die Implementierung Zeit sparender ...
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/13/2017)... Feb. 13, 2017 Former 9/11 Commission border ... Committee, Janice Kephart of Identity Strategy Partners, ... Donald Trump,s "Executive Order: Protecting the Nation From ... 2017):  "As President Trump,s ,Travel Ban, Executive ... now essentially banned the travel ban, it is important ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... 27, 2017  The global market for clinical ... to a new report from Kalorama Information.  In ... performed to evaluate disease progression, monitor drug treatment ... reasons.  The healthcare market research firm,s report, ... an overview of the medical laboratory industry and ...
(Date:3/27/2017)... ... ... PMG Research is pleased to announce its participation in the 2nd ... Boston on April 3-4, 2017. The CTC conference focuses on how the industry is ... closer to the patient. Clinical Trial Collaborations also will present an inaugural conference on ...
(Date:3/27/2017)... 2017 DarioHealth Corp. (NASDAQ: DRIO), a leading ... data solutions, today announced that it is now offering ... U.S. consumers who want to have their DarioHealth products ... strategic alliance agreements with partners across the U.S. who ... if approved, will supply and bill the customer,s insurance ...
(Date:3/24/2017)... and ROCKVILLE, Md. , March 24, ... Maxwell Biotech Venture Fund (MBVF), today announced positive results ... to the standard drug therapy regimen in patients with ... molecule drug discovered by scientists at Sequella, Inc. ( ... of Health. A total of 140 ...
Breaking Biology Technology: